No more than 15 authors can be listed.Please ensure the authors are listed in the right order.If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.
Bronchial provocation testing is traditionally interpreted using spirometric changes in forced expiratory volume in one second. However, spirometry is relatively insensitive to small airway dysfunction and may fail to detect early or peripheral airway hyperresponsiveness. Oscillometry allows assessment of airway resistance and reactance and may improve detection of small airway disease.
A 57-year-old woman presented with intermittent dyspnoea and chest tightness. Baseline spirometry was normal. Mannitol bronchoprovocation testing was performed using standard spirometric criteria and was negative, with no significant fall in forced expiratory volume in one second.
Forced oscillation testing was performed at baseline and repeated at peak mannitol exposure. At maximal challenge dose, oscillometry demonstrated marked abnormalities in small airway indices, including increased reactance area and frequency dependence of resistance. Post-bronchodilator oscillometry demonstrated significant reversibility, with improvements in total airway resistance, frequency dependence of resistance, and reactance area, consistent with reversible small airway dysfunction.
These findings established a diagnosis of small airway asthma despite a negative spirometric bronchoprovocation response.
This case illustrates an important limitation of spirometry-based bronchoprovocation testing in detecting small airway asthma. Oscillometry performed during bronchial challenge can reveal physiologically significant peripheral airway dysfunction that may be missed by conventional spirometric criteria.
We propose a pragmatic protocol integrating oscillometry into bronchoprovocation testing: baseline spirometry and oscillometry, standard bronchial provocation, repeat oscillometry if spirometric criteria are positive or maximal challenge dose is reached, and post-bronchodilator oscillometry to confirm reversibility.
Integration of oscillometry into bronchoprovocation testing may improve detection of small airway asthma and provide additional physiological insight when spirometry is normal or inconclusive.